[15] However, subsequent analysis revealed important context: the increased risk was predominantly observed in patients with pre-existing diabetic retinopathy and those who experienced rapid improvements in glycaemic control
Liraglutide could also be used in those with a high risk of cardiovascular disease, based on risk factors such as hypertension and dyslipidaemia
We proposed that this model would apply to all clinicians meeting the eligibility criteria, regardless of whether the clinician is exempt from MIPS reporting during ASM's performance year due to QP status or Partial QP status as a result of meeting the thresholds for payments or patients tied to participation in an Advanced APM
This matters because any future trials at the GLP-1/TRT intersection will be judged on whether low testosterone serum levels are rigorously defined (symptoms plus biochemical confirmation), whether measurements are repeated and standardized, and whether confounding reversible contributors (e.g., acute illness, medication effects, sleep disturbance, severe caloric restriction, or increased aromatization associated with excess adiposity) are addressed
Supplied exclusively for qualified laboratory and scientific research